Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 32.00
Ask: 33.00
Change: 0.25 (0.78%)
Spread: 1.00 (3.125%)
Open: 32.25
High: 32.50
Low: 32.25
Prev. Close: 32.25
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Jun 2014 07:00

RNS Number : 8277K
Praetorian Resources Limited
30 June 2014
 



30 June 2014

 

 

Praetorian Resources Limited ("Praetorian" or the "Company")

 

Issue of new shares

 

During July 2013 the Company announced that the majority of the Directors and advisors had agreed to accrue their contractual fees from 31 March 2013 as part of a cost saving and cash enhancement initiative. Those fees, in respect of services provided by two former directors, Mark Hohnen and Richard Lockwood and to two advisers, Malcolm Burne and Charles Cannon-Brookes have been accrued on the Company's balance sheet to date.

 

In line with this cash enhancement initiative, the Company has agreed with Messrs Hohnen, Lockwood, Burne and Cannon-Brookes to settle these accrued fees by the issue of 2,000,000 new Praetorian ordinary shares of no par value ("Ordinary Shares") representing a material discount to the combined total outstanding value of these contracts, which inclusive of notice periods equates to £297,500. Of these, 1,725,000 Ordinary Shares will be issued to Arlington Group Asset Management Limited (a company owned in equal share by Mr. Burne, Mr. Cannon-Brookes and Mr. Lockwood that contracts for their services) and 275,000 Ordinary Shares will be issued to Mark Hohnen. As a condition of this settlement, both Mr. Lockwood and Mr. Cannon-Brookes have agreed not to charge any further fees for the services they provide as part of the Advisory and Execution Team.

 

The placing of these Ordinary Shares constitutes a related party transaction under Rule 13 of the AIM Rules for Companies. The Director's, having consulted with the Company's nominated adviser, Grant Thornton UK LLP, consider that the terms of the transaction are fair and reasonable in so far as the Company's shareholders are concerned.

 

Application will be made for the admission to trading on AIM of the 2,000,000 new Ordinary Shares with admission expected to take place on or around 4 July 2014. Following admission, the Company's issued share capital will be 45,635,936 Ordinary Shares with each Ordinary Share carrying the right to one vote. The figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Disclosure and Transparency Rules.

 

The Company has in issue 23,205,443 subscription shares which carry voting rights only in limited circumstances. Subscription shareholders are not required to notify their interest in, or a change to their interest in, subscription shares under the Disclosure and Transparency Rules.

 

Robert King, Chairman stated:

"These most recent cash conservation initiatives will assist in retaining the Company's operating costs below GBP 250,000 per annum. I am pleased that Richard Lockwood and Charles Cannon-Brookes have agreed to continue to advise the Company without further charges, preferring to benefit from any uplift in the Company's share price.

 

The Board remain cognisant of the fact that the Company is undercapitalised and our focus remains on maximising the value from the existing portfolio while also actively searching for strategic opportunities to bring renewed positive momentum and scale to Praetorian."

 

 

 

 

Contacts:

For further information, please contact:

Praetorian Resources Limited

Robert King, Chairman

+44 (0) 1481 732 153

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson/David Hignell/Jamie Barklem

+44 (0)20 7383 5100

Pareto Securities Limited (Broker)

Guy Wilkes

+44 (0)20 7786 4370

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQDLFLZQFEBBF
Date   Source Headline
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update
21st Jun 20227:00 amRNSInterim Dividend and Dividend Declaration
1st Jun 20224:25 pmRNSHolding(s) in Company
27th May 20229:08 amRNSDirector / PCA Dealings
26th May 20223:23 pmRNSResult of General Meeting and Issue of Equity
11th May 20227:05 amRNSRaises £20m through Placing and PrimaryBid Offer
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.